Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06793891 · ClinicalTrials.gov registry record · NA

Effects of Ashwagandha Extract on Stress Levels

A NA study of Stress, sponsored by Nutraceuticals Research Institute.

Recruiting
Registry status
NA
Development phase
60
Enrollment target
1
Study location

NCT06793891 is a NA study of Stress that is actively recruiting participants, run by Nutraceuticals Research Institute. The registered enrollment target is 60 participants, below the 786-participant average among 152 other Stress trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06793891, a NA study of Stress, is actively recruiting participants, sponsored by Nutraceuticals Research Institute.

RECRUITING
Registry status
NA
Development phase
60 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to evaluate the efficacy of two proprietary ashwagandha extracts on stress levels, with secondary outcomes of cognition, energy, and sleep, as compared to a placebo.

Conditions Studied

Interventions

  • OTHER placebo
  • DIETARY_SUPPLEMENT ashwagandha root
  • DIETARY_SUPPLEMENT ashwagandha root and leaf

Study Locations (1)

Alabama

  • Nutraceuticals Research Institute - Huntsville

Trial Details

FieldValue
Enrollment Target 60 participants
Start Date 2024-10-21
Est. Completion 2025-04-30
Phase NA

Sponsor

Nutraceuticals Research Institute

15 total trials

What the Registry Record Tells You About NCT06793891

The ClinicalTrials.gov registry entry for NCT06793891 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 60 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 786-participant average among 152 other Stress trials with a reported enrollment target (92% lower). The listed sponsor is Nutraceuticals Research Institute, which has 15 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Stress appearing as the primary indexed condition, and to 3 interventions - of which placebo is the first listed.

NCT06793891 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06793891 about?

NCT06793891 is a clinical study titled "Effects of Ashwagandha Extract on Stress Levels". The purpose of this study is to evaluate the efficacy of two proprietary ashwagandha extracts on stress levels, with secondary outcomes of cognition, energy, and sleep, as compared to a placebo.

What is the current status of trial NCT06793891?

This trial is currently recruiting. It is a NA study. The enrollment target is 60 participants. The study started on 2024-10-21. Estimated completion is 2025-04-30.

What conditions does trial NCT06793891 study?

This clinical trial studies the following conditions: Stress.

What interventions are being tested in trial NCT06793891?

The interventions under investigation include: placebo (OTHER), ashwagandha root (DIETARY_SUPPLEMENT), ashwagandha root and leaf (DIETARY_SUPPLEMENT).

Who is sponsoring clinical trial NCT06793891?

This trial is sponsored by Nutraceuticals Research Institute, which has 15 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06793891 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Stress

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.